Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors.
The Global Artificial Pancreas Device Systems Market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2016-2025. Driving factors such as, growing prevalence of diabetes, developments by major players, rise in demand for computerized systems for glycemic control are expected to boost the market growth over the years.
Diabetes Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Global electrophysiology devices market is projected to display a robust growth represented by a CAGR of 12.54 % during 2018 – 2023.
Just 20 in number, but your baby’s teeth are bound to be infected soon if you forget to take care of them.
Hal Brickman – Over 40 Years of Couples Counseling Experience in Manhasset, Great Neck, Glen Cove, Roslyn Heights, and NYC. Mr. Hal and Allia Brickman help to improve communication between partners and within families. Call us at 516-439-4282 to Book an appointment today for marriage counseling, relationship counseling for couples and family therapy.
Depression is a common mental disease among men and women. It changes the victim’s moods in a negative way.
Bharat Book Bureau Provides the Trending Market Research Report on “Brain Tumor Therapeutics: Global Markets to 2023”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. The Global Brain Tumor Therapeutics Market was valued at REDACTED in 2017 and is expected to witness a compound…
In the report the orthopedic medical robots market, the market is expected to reach US$ $ 2,110.69 Mn in 2025 from US$ 375.49 in 2017. The market is estimated to grow with a CAGR of 24.1% from 2018-2025.
The market for bispecific antibodies is quiet bright as they are the new emerging trends in the market. BsAbs due their specificity are gaining a lot of interest from multiple stake holders from the pharmaceutical industry. Now with the improved technology, monoclonal antibody therapy witnessed a drastic transition and is becoming more acceptable due to its site specific approach.